2-(4-(Morpholinomethyl)-1H-1,2,3-triazol-1-yl)-N-(7-(4-(pyridin-3-yl)-1H-1,2,3-triazol-1-yl)heptyl)benzamide

ID: ALA4569066

PubChem CID: 155550884

Max Phase: Preclinical

Molecular Formula: C28H35N9O2

Molecular Weight: 529.65

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCCCCCCCn1cc(-c2cccnc2)nn1)c1ccccc1-n1cc(CN2CCOCC2)nn1

Standard InChI:  InChI=1S/C28H35N9O2/c38-28(25-10-4-5-11-27(25)37-21-24(31-34-37)20-35-15-17-39-18-16-35)30-13-6-2-1-3-7-14-36-22-26(32-33-36)23-9-8-12-29-19-23/h4-5,8-12,19,21-22H,1-3,6-7,13-18,20H2,(H,30,38)

Standard InChI Key:  BTBLXXRZUHCDOF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    2.8251  -31.1315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6488  -31.1326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0620  -30.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6484  -29.7106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8214  -29.7134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4162  -30.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8906  -30.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3775  -31.0861    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1628  -30.8324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1630  -30.0068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3778  -29.7530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8698  -29.5909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5887  -29.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3008  -29.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0196  -29.9838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7317  -29.5672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4507  -29.9719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1627  -29.5553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8774  -29.9601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5895  -29.5393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3084  -29.9482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5826  -28.7138    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3123  -30.7742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0304  -31.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7434  -30.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7339  -29.9325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0153  -29.5275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0038  -28.7051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6595  -28.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3959  -27.4362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5733  -27.4476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3273  -28.2335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1045  -27.0147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8236  -27.4234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8272  -28.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5420  -28.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2565  -28.2388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2514  -27.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5319  -26.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11  7  2  0
  3  7  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 21  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 28  1  0
 30 33  1  0
 33 34  1  0
 34 35  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4569066

    ---

Associated Targets(Human)

SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nampt Nicotinamide phosphoribosyltransferase (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 529.65Molecular Weight (Monoisotopic): 529.2914AlogP: 3.13#Rotatable Bonds: 13
Polar Surface Area: 115.88Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.80CX LogP: 3.13CX LogD: 3.13
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.26Np Likeness Score: -1.90

References

1. Travelli C, Aprile S, Mattoteia D, Colombo G, Clemente N, Scanziani E, Terrazzino S, Alisi MA, Polenzani L, Grosa G, Genazzani AA, Tron GC, Galli U..  (2019)  Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group.,  181  [PMID:31400709] [10.1016/j.ejmech.2019.111576]

Source